"How Bayer Makes Decisions to Develop New Drugs."

Jeffrey S. Stonebraker (2002)

> Home

Details and statistics

DOI: 10.1287/INTE.32.6.77.6475

access: closed

type: Journal Article

metadata version: 2020-03-27

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/interfaces/Stonebraker02
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/interfaces/Stonebraker02
Jeffrey S. Stonebraker:
How Bayer Makes Decisions to Develop New Drugs. Interfaces 32(6): 77-90 (2002)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.